Plasma or urine APE1/Ref-1 levels are significantly increased in patients with bladder cancer; area under the curve analysis revealed the diagnostic values of APE1/Ref-1 with high specificity and sensitivity [67,68]. Here, APEX1 is linked to urinary bladder carcinoma.